Matthew Reaney, UK

Matt is a Chartered and Practitioner Health Psychologist, a Chartered Scientist, a Fellow of both the Royal Societies of Medicine and Public Health, and an Associate Fellow of the British Psychological Society.  Matt is the Global Head of Clinical Outcomes at Sanofi, focusing on understanding and measuring patient-relevant outcomes and experiences in a scientifically sound way. This includes both outcome evaluation for clinical drug development and the support of patients in routine clinical practice. Matt is also pursuing his PhD (latterly) at the University of Chichester in the UK. He particularly interested in understanding and embracing patient heterogeneity in defining outcome measures such as benefit-risk and patient perception and preference, and improving healthcare through the careful measurement and feedback of relevant concepts. In addition to his work at Sanofi and Chichester, Matt lectures at Royal Holloway University of London, is a co-chair of the Drug Information Association Study Endpoints Group and is an advisor to various Patient-centred research organisations and committees including ISOQOL.